GLP-1 Weight Loss: The Challenge of Sustained Results
A study of 1.2M patients reveals 58% regain weight after stopping GLP-1 drugs like Wegovy & Ozempic. Highlights the challenge of sustained weight loss and the need for chronic management.
A study of 1.2M patients reveals 58% regain weight after stopping GLP-1 drugs like Wegovy & Ozempic. Highlights the challenge of sustained weight loss and the need for chronic management.